Home > Node

How a plant grows

A cutting edge production facility in Sofia.

Sofia, 2013. A new Sopharma AD era for innovation and production.

We are proud to cut the ribbon on our newly built manufacturing facility in Sofia. We have modernized every existing facility we inherited from the state with the privatization of the company. Building a brand new solid dosage forms facility from scratch was a great experience and achievement for us.

THE PLANT IN NUMBERS

English

Information about treasury shares

SOPHARMA AD hereby informs that from 7 July 2016 up to and including 13 July 2016 the Company bought 177 877 own shares representing 0.13% of the share capital of the Company, at a total value of 454 531.32 BGN on the Bulgarian Stock Exchange, the average price per share was 2.555 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 398 873, representing 4.01% of the share capital of the Company.

English

Sales revenues for First Half of 2016

For the first six months of this year, revenues from sales decreased by 10% compared to the same period of 2015, including 3% decrease of domestic sales and a 15% decrease of export sales.

English

Children’s Tennis Camp for the Children of Sopharma Employees

Sopharma AD provided a free tennis camp for the children of its employees that took place on the courts of the National Tennis Centre. With coaches and all-day special program, the children acquired new skills in a healthy environment, new friends and positive emotions.

English

Band Investors

85+ year track record in the pharma industry

English

Expanding the OTC portfolio

Sopharma has a tradition in OTC products from natural herbal extracts. Several of our distinguished products are of such origin. These are the well established brands like Carsil, Tribestan, Nivalin etc.

TUSPAN syrup is the newest addition to our OTC portfolio based on extract of ivy leaf. The already popular coughing syrup we believe will be new star in our OTC portfolio.

English

Pages